Physician profile
Justin Thompson
NPI 1275851719
$44,535.29
in general payments reported to CMS, 2019-2025
34 companies · $15K in 2025
The $15K reported for 2025 was more than what 98% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,683 · 2020: $1,329 · 2021: $3,894 · 2022: $5,935 · 2023: $8,881 · 2024: $6,399 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $9,772 · Travel and Lodging: $5,969 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Entertainment: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,000.00 |
| Food and Beverage | $9,771.78 |
| Travel and Lodging | $5,968.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Entertainment | $153.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $15,745.02 | 2023-2025 | |
| Medtronic, INC. | $6,634.13 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Boston Scientific Corporation | $3,031.98 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Abbott Laboratories | $2,941.46 | 2019-2025 | Proclaim |
| Mml US, INC. | $2,449.55 | 2023 | Reactiv8 |
| Saluda Medical Americas, INC. | $2,315.94 | 2023-2024 | Evoke Scs, Evoke |
| Nevro Corp. | $2,198.85 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $1,740.95 | 2021 | |
| Painteq LLC | $1,239.40 | 2021-2022 | |
| Relievant Medsystems, INC. | $1,063.94 | 2022-2023 | Intracept |
| Vertiflex, INC. | $1,043.74 | 2019 | |
| Medtronic USA, INC. | $992.36 | 2019-2020 | |
| Abbvie INC. | $582.74 | 2020-2025 | Ubrelvy, Qulipta, Botox |
| Spr Therapeutics, INC | $450.64 | 2022-2024 | Sprint Pns System |
| Arthrex, INC. | $288.20 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $276.18 | 2019-2023 | Sublocade |
| Stimwave Technologies Incorporated | $233.39 | 2020-2021 | |
| Orthofix Medical, INC. | $223.46 | 2023 | Forza, Sambascrew, Firebird |
| Vertos Medical, INC. | $156.45 | 2021 | |
| Flowonix Medical Incorporated | $153.10 | 2019 | |
| Curonix LLC | $146.94 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pylant Medical | $127.20 | 2025 | |
| Microport Orthopedics INC | $105.02 | 2019 | |
| Scilex Pharmaceuticals INC. | $104.05 | 2019 | |
| Ge Healthcare | $77.38 | 2021 | |
| Pfizer INC. | $42.79 | 2019 | |
| Nalu Medical, INC. | $40.87 | 2022-2023 | Nalu Neurostimulation System |
| Hikma Pharmaceuticals USA | $34.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.26 | 2025 | |
| Globus Medical, INC. | $18.02 | 2025 | Senza |
| Daiichi Sankyo INC. | $16.30 | 2019 | |
| Theragen, INC. | $15.00 | 2022 | |
| Allergan, INC. | $14.60 | 2021 | |
| Acera Surgical, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.